Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2020-12-04 09:28:58
Moss, 04 December 2020<br />
<br />
Reference is made to the annual general meeting held on 14 May 2020 where a
resolution to grant an authorisation for a share issue in connection with an
employee share purchase program (ESPP) was resolved.<br />
<br />
Gentian Diagnostics AS is pleased to announce that it has decided to conduct a
share issue towards company employees that has subscribed for shares in the
ESPP. Under the terms of the ESPP, all employees have been given the opportunity
to subscribe for shares up to a maximum amount of NOK 25,000. The Company has
decided to award a 20% discount to the volume weighted average price between 9
November and 20 November, resulting in a subscription price of NOK 50.38 per
share. More than 50% of the employees have subscribed for shares and a total of
9,171 shares will be issued raising a gross proceed of NOK 462,000. Following
the completion of the offering and the issue of the New Shares, Gentian's share
capital will increase by NOK 917.10 to NOK 1,541,188.9 comprising 15,411,889
shares with a nominal value of NOK 0.10 per share.<br />
<br />
<br />
For further information, please contact:<br />
Hilja Ibert<br />
CEO, Gentian Diagnostics<br />
E-mail: hilja.ibert@gentian.no<br />
Cell Phone: +47 919 05 242<br />
<br />
Njaal Kind<br />
CFO, Gentian Diagnostics<br />
E-mail: njaal.kind@gentian.no<br />
Cell Phone: +47 919 06 525